Long-term efficacy of total and partial posterior fundoplication to treat gastroesophageal reflux disease
Editorial Commentary

Long-term efficacy of total and partial posterior fundoplication to treat gastroesophageal reflux disease

Rafael Cauê Katayama^, Ana Clara Lopes de Grande, Fernando Augusto Mardiros Herbella

Division of Surgical Gastroenterology, Department of Surgery, Universidade Federal de São Paulo-UNIFESP, São Paulo, Brazil

^ORCID: 0000-0001-9403-8971.

Correspondence to: Dr. Rafael Cauê Katayama. Division of Surgical Gastroenterology, Department of Surgery, Universidade Federal de São Paulo-UNIFESP, 1123 Tabapua St, rm 21, São Paulo 04533-010, Brazil. Email: caue.katayama@unifesp.br.

Comment on: Analatos A, Håkanson BS, Ansorge C, et al. Clinical Outcomes of a Laparoscopic Total vs a 270° Posterior Partial Fundoplication in Chronic Gastroesophageal Reflux Disease: A Randomized Clinical Trial. JAMA Surg 2022;157:473-80.


Received: 28 July 2022; Accepted: 15 August 2022; Published: 30 December 2022.

doi: 10.21037/dmr-22-53


Surgical treatment is a well-established therapeutic option for gastroesophageal reflux disease (GERD). Laparoscopic fundoplication has been reported as advantageous since it restores the anatomical and functional disorders related to GERD (1). However, performing a fundoplication means acting on the balance between GERD control and some possible adverse effects, such as dysphagia. This issue is not new but has called for a recent discussion on pros and cons comparing different types of fundoplication.

In this article of JAMA Surgery, Analatos et al. (2) reported a randomized clinical trial comparing 270° partial fundoplication (PF) vs. 360° total fundoplication (TF) for GERD treatment in a long term (15-year) follow-up. Patient’s demographic characteristics were presented, and groups were comparable. Clinical dysphagia scores markedly improved after the procedures in both groups and was maintained during the entire follow-up. Although the same group had reported some small differences in dysphagia rates favorable to PF in a short follow-up (3,4), those differences disappeared over time. These findings corroborate the results published in other trials, systematic review and meta-analysis comparing TF and PF in short and long-term follow-up (5-7). GERD control based on symptoms questionnaires was similar between groups.

The authors reported almost 30% loss of follow-up. Although this is common in long-term studies, this could be considered as a limitation. On the other hand, they obtained an acceptable number of patients (159 PF and 151 TF) who had concluded the 15 years follow-up which should be considered when looking over the results.

Although typical GERD symptoms are often sufficient to determine the diagnosis (8), the lack of objective data, mainly 24 hours pH monitoring, should also be a limitation. A subjective evaluation of GERD control and dysphagia could explain the convergence of results toward equity between the procedures. Besides, it is well known both TF and PF when successfully performed increases lower esophageal sphincter pressure and the strength of esophageal peristalsis in patients with abnormal preoperative esophageal motility commonly observed in patients with GERD (9). This can explain low and similar rates in dysphagia symptoms after the procedures. The lack of objective measurement of GERD and esophageal motility is a limiting factor. Nevertheless, this study is important evidence that both procedures are efficient in GERD control with low rates of side effects, mainly dysphagia. The authors also evaluated the intake of proton pump inhibitors (PPIs) as part of the evaluation. Although there remains a worrysome continuous increase over time in the number of patients who are prescribed PPI after the operations (25% in the 15-year follow-up of this study), it is important to understand the reason for this increasing need of PPI. Interestingly, although many patients use PPIs after anti-reflux surgery, only one-third have objective evidence of recurrent reflux when tested by pH monitoring (10). It is possible that PPIs prescription after surgery are related to gastric symptoms, extra esophageal symptoms, or they are over prescribed once most patients who are taking PPIs don’t have evidence of de novo GERD. This is controversial and studies with better methodology are needed to get through this issue.

In conclusion, Analatos et al. provides evidence that PF and TF are excellent options for GERD improvement with similar rates of side effect symptoms. Despite the presented results, choosing the type of fundoplication should be assisted by 24 hours pH monitoring and esophageal manometry respecting the individual characteristics of each patient.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was commissioned by the editorial office, Digestive Medicine Research. The article did not undergo external peer review.

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure forms (available at https://dmr.amegroups.com/article/view/10.21037/dmr-22-53/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Allaix ME, Herbella FA, Patti MG. Laparoscopic total fundoplication for gastroesophageal reflux disease. How I do it. J Gastrointest Surg 2013;17:822-8. [Crossref] [PubMed]
  2. Analatos A, Håkanson BS, Ansorge C, et al. Clinical Outcomes of a Laparoscopic Total vs a 270° Posterior Partial Fundoplication in Chronic Gastroesophageal Reflux Disease: A Randomized Clinical Trial. JAMA Surg 2022;157:473-80. [Crossref] [PubMed]
  3. Håkanson BS, Lundell L, Bylund A, et al. Comparison of Laparoscopic 270° Posterior Partial Fundoplication vs Total Fundoplication for the Treatment of Gastroesophageal Reflux Disease: A Randomized Clinical Trial. JAMA Surg 2019;154:479-86. [Crossref] [PubMed]
  4. Analatos A, Lindblad M, Ansorge C, et al. Total versus partial posterior fundoplication in the surgical repair of para-oesophageal hernias: randomized clinical trial. BJS Open 2022;6:zrac034. [Crossref] [PubMed]
  5. Mardani J, Lundell L, Engström C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg 2011;253:875-8. [Crossref] [PubMed]
  6. Broeders JA, Mauritz FA, Ahmed Ali U, et al. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg 2010;97:1318-30. [Crossref] [PubMed]
  7. Broeders JA, Roks DJ, Ahmed Ali U, et al. Laparoscopic anterior versus posterior fundoplication for gastroesophageal reflux disease: systematic review and meta-analysis of randomized clinical trials. Ann Surg 2011;254:39-47. [Crossref] [PubMed]
  8. Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review. JAMA 2020;324:2536-47. [Crossref] [PubMed]
  9. Herbella FA, Tedesco P, Nipomnick I, et al. Effect of partial and total laparoscopic fundoplication on esophageal body motility. Surg Endosc 2007;21:285-8. [Crossref] [PubMed]
  10. Schlottmann F, Herbella FA, Allaix ME, et al. Surgical Treatment of Gastroesophageal Reflux Disease. World J Surg 2017;41:1685-90. [Crossref] [PubMed]
doi: 10.21037/dmr-22-53
Cite this article as: Katayama RC, de Grande ACL, Herbella FAM. Long-term efficacy of total and partial posterior fundoplication to treat gastroesophageal reflux disease. Dig Med Res 2022;5:51.

Download Citation